Company / Total Assets
Viking Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$715.7M
FY2025
5-year range
$168.5M / $908.3M
FY2021-FY2025
Trend
-21.2%
vs FY2024
Sector context
#107 of 214
Health Care
What the data says
At $716M, Viking Therapeutics, Inc.'s total assets ranks #107 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $15M in FY2016 to $908M in FY2024.
Based on SEC 10-K filings.
$716M in FY2025 with a 5-year CAGR of +22.8%.
Improved from $368M to $716M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +61.9%
- 5-Year CAGR
- +22.8%
- 10-Year CAGR
- -
Sector benchmark
#107 of 214 in Health CareTop 50% of 214This company $715.7M Sector average $7.5B
▼
-90.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.8%, indicating consistent growth.
- In FY2025, total assets decreased 21.2% year-over-year.
- Ranks #107 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $715.7M | -21.2% |
| FY2024 | $908.3M | +146.5% |
| FY2023 | $368.5M | +118.7% |
| FY2022 | $168.5M | -20.0% |
| FY2021 | $210.7M | -17.9% |
| FY2020 | $256.5M | -9.8% |
| FY2019 | $284.3M | -6.0% |
| FY2018 | $302.3M | +1266.6% |
| FY2017 | $22.1M | +52.2% |
| FY2016 | $14.5M | -5.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026